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The Saccharomyces cerevisiae protein Prp5 is a mem-
ber of the “DEAD box” family of putative RNA-depend-
ent ATPases and helicases. The protein was purified
from Escherichia coli and determined to be an RNA-de-
pendent ATPase. The ATPase activity is 7-fold more spe-
cific for full-length U2 than for any of the other small
nuclear RNAs or nonspecific RNAs tested. An RNaseH
assay in extracts was used to demonstrate that Prp5
mediates an ATP-dependent conformational change in
the intact U2 small nuclear ribonucleoprotein. We pro-
pose that this conformational change makes the branch
point pairing sequence of U2 RNA accessible for pair-
ing with the intron allowing formation of the
pre-spliceosome.
Splicing of introns in nuclear pre-mRNA takes place in a
complex structure, the spliceosome, which is assembled de novo
for each splicing event. Once assembled, the spliceosome cata-
lyzes two sequential trans-esterification reactions that remove
the intron from the pre-mRNA and ligates the exons. In the
first reaction, the 29-OH of a particular adenosine residue near
the 39 splice site attacks the phosphodiester bond at the 59
splice site giving the intermediates in the reaction, exon 1, and
the lariat intron, exon 2, a branched structure in which the
59-nucleotide is connected to the branch point adenosine via a
29-59 phosphodiester bond. In the second reaction, the 39-OH of
exon 1 attacks the phosphodiester bond at the 39 splice site,
resulting in the formation of the spliced mRNA product and
releasing the intron in lariat form (1–3).
The group II self-splicing introns are spliced by an identical
pathway, leading to the principal tenets of this field that
pre-mRNA splicing is an RNA-catalyzed reaction and that the
two processes share a distant evolutionary ancestor (4).
The spliceosome contains five ribonucleoprotein particles,
snRNPs,1 called U1, U2, U4, U5, and U6 and is assembled
stepwise in a dynamic process in which the pre-mRNA and the
snRNAs undergo a series of base pairing interactions resulting
finally in the catalytically competent structure, presumably a
structure sharing common chemical and catalytic features with
the group II self-splicing introns. The process of spliceosome
assembly is quite different from the other complex ribonucleo-
protein machine with which it can be compared, the ribosome
(5). The ribosome can self-assemble from pure RNA and protein
components in vitro without the requirement for ATP hydrol-
ysis or trans-acting proteins. The unique essence of pre-mRNA
splicing is to be found in the ordered and precise assembly
steps all but the first of which require ATP hydrolysis.
Yeast genetic studies of proteins absolutely required for
pre-mRNA splicing has thus far revealed only one source of the
ATP requirement in spliceosome assembly. The proteins Prp2,
Prp5, Prp16, Prp22, and Prp28 are all members of a superfam-
ily defined by the first member of the family, the eukaryotic
translation initiation factor eIF-4a (6–11). These proteins
share a number of sequence motifs including a characteristic
ATP binding site which includes the sequence DEAD, giving
rise to one name for the family, the DEAD box proteins (12).
DEAD box proteins are ubiquitous in nature. They have been
found in all three major lines of descent, the bacteria, the
archaebacteria, and the eukaryotes and usually in multiple
copies. There are at least five in Escherichia coli. A recent data
base search of the almost completed yeast genome found at
least 66 DEAD- or DEAH-related genes, and extrapolating
from the completed 2% of the Caenorhabditis elegans genome
sequence there are probably at least 100 in higher eukaryotes.
Biochemical studies of the DEAD box proteins almost invari-
ably reveal that they are RNA-dependent ATPases, and in a
few cases they have been shown to be RNA helicases, that is
they can separate the strands of double-helical RNA in an
ATP-dependent reaction so they have also been called RNA
helicases (13–17). However, the latter reaction cannot be dem-
onstrated for most of the proteins, so a safer term for the DEAD
box proteins required for pre-mRNA splicing might be “spliceo-
somal ATPases.”
Studies on the role of the spliceosomal ATPases in assembly
suggest that each ATP-dependent step might be mediated by a
single family member. The formation of the pre-spliceosome, an
early intermediate in the pathway containing only the U1 and
U2 snRNPs, requires Prp5 and the consecutive steps at the end
of the pathway; activation of the spliceosome, activation of the
second step, and release of the products require in order Prp2,
Prp16, and Prp22, all members of a subclass of this family
which share, instead of DEAD, a DEAH sequence and which
are homologous over an additional 300 amino acids at their C
termini (9–11, 18). What reaction could these proteins be cat-
alyzing in the spliceosome assembly? The assembly pathway is
punctuated by a series of RNA rearrangement that could better
be understood as strand displacement reactions or structural
isomerizations than helical disruptions (3). Thus a working
hypothesis is that each structural isomerization is mediated by
a specific spliceosomal ATPase. Clearly to understand exactly
what these proteins are doing and how they do it must be a
major objective for the study of pre-mRNA splicing, indeed for
biochemistry since, as a class, these proteins are involved in a
wide range of RNA-protein interactions.
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A possible reason why specific reactions have not been ob-
served for any of the spliceosomal ATPases is that they work in
combination with other proteins. eIF-4A has little if any heli-
case activity on its own, but in conjunction with eIF-4B, it has
a weak but detectable helicase activity (13). However, p68 has
strong RNA helicase activity on its own (15). It is possible that
the spliceosomal ATPases act together with other proteins or
act in the context of the snRNP or a spliceosome intermediate.
In this regard, genetic studies suggest either a physical or
functional interaction between Prp5 and three proteins, Prp9,
Prp11, and Prp21, which have been shown by biochemical and
genetic experiments to be tightly associated (19–22). The ge-
netic studies also suggest an interaction between Prp5 and U2
RNA (21, 23, 24).
To understand how Prp5 functions, we have expressed the
protein in E. coli and purified it to homogeneity. Like other
spliceosomal ATPases Prp5 is an RNA-dependent ATPase, but
unlike other members of this family it exhibits a weak but real
specificity for U2 RNA, presumably its in vivo substrate. We
also demonstrate an interesting ATP-dependent conforma-
tional change in the U2 RNA within the context of the snRNP.
These studies are the basis for continuing efforts to understand
just how and what Prp5 does to facilitate the formation of the
pre-spliceosome.
EXPERIMENTAL PROCEDURES
Materials—Pet 19 vector was purchased from Novagen. Isopropyl-1-
thio-b--galactopyranoside was purchased from Calbiochem. Ni-NTA
resin was from Qiagen. Superose 12, Mono Q, and S FPLC columns
were from Pharmacia Biotech Inc. Polyethyleneimine cellulose plates
were from Brinkman. GeneClean was purchased from BIO101. A ran-
dom priming kit was from Boehringer Mannheim. Analysis was per-
formed on a Molecular Dynamics PhosphorImager using Imagequant
software.
Oligonucleotides—4A, 59-CTTGGTCACACACACATACGGCGCGGA-
AGGCGTGTTTGCTGAC-39; 4B, 59-GGAAACGTCAGCAAACACGCC-
TTCCGCGCCGTATGTGTGTGTGAC-39; 5A, 59-GTTTCCGAAAGGA-
ACGGGTGGATCTTATAATTTTTGATTTATTTTAA-39; 5B, 59-AGCT-
TTAAAATAAAYCAAAAATTATAAGATCCACCCGTTCCTTTC-39.
Expression and Purification of Prp5—An NdeI site was placed by
site-directed mutagenesis in the 59 end of the gene corresponding to the
primary methionine. An NdeI-BamHI fragment was then placed into a
NdeI-BamHI-cleaved pET19 vector supplied by Novagen. This plasmid
contains 10 N-terminal histidines followed by the enterokinase cleav-
age site. The PRP5 gene was inserted immediately following this site
starting with its terminal methionine. Other constructs were made
containing the N-terminal flag peptide, but the pET 19 version was
used for purification. The plasmid was transformed into a BL21-pLysS
strain of E. coli. 10 liters of the transformed cells were grown to 40 klett
units and induced with 0.5 mm isopropyl-1-thio-b-galactopyranoside.
The cells were grown for an additional 4.5 h, harvested, washed, and
resuspended in 50 MM sodium phosphate, pH 7.0, 0.75 M NaCl, 10%
glycerol, 10 mM b-mercaptoethanol, 5 mM Imidizole. The resuspended
cells were lysed on ice by sonication for two 1-min bursts with a 1-min
chill between bursts. The lysate was spun for 30 min to remove debris.
The supernatant was cleared of nucleic acids by adding polyethylene-
imine to 1% while stirring for 1⁄2 h. The lysate was cleared by ultracen-
trifugation for 1 h at 42,000 rpm in a Ti50 rotor.
The lysate was then loaded on a 2 ml of NTA metal chelating column.
The lysate was loaded at 0.25 ml/min and washed with 10-column
volumes of the loading buffer. Step elutions were carried out in 4
column volumes by increasing the imidizole to 40, 80, and then 200 mM.
Prp5 mostly eluted in the 80 mM eluant as verified by immunoblot
analysis.
The 80 and 200 mM eluants were pooled and dialyzed against 20 mM
Mes, pH 6.5, 100 mM NaCl, 10% glycerol, 1 mM DTT, 1 mM EDTA and
loaded on a Sepharose S (Pharmacia) FPLC column equilibrated in the
same buffer. The proteins were eluted in a gradient from 0.1 to 1 M
NaCl. 250 1-ml fractions were collected and analyzed. Fractions con-
taining Prp5 were pooled and dialyzed in 50 mM Tris, pH 8.0, 100 mM
NaCl, 10% glycerol, 1 mM EDTA, 1 mM DTT. The protein was then
loaded on a Mono Q (Pharmacia) FPLC column equilibrated in the same
buffer and eluted with a gradient of 100 to 750 mMNaCl. Fractions were
analyzed for ATPase activity and the presence of Prp5 by immunoblot
analysis. Peak ATPase activity correlated with the peak of Prp5 pro-
tein. Total yield of protein was about 200 mg.
Reconstitution of prp5-1 and prp5-3 Extracts—prp5-1 and prp5-3
extracts were prepared as described (25). Extracts were inactivated for
30 min at 37 °C. Control extracts were incubated at room temperature.
For RNA splicing reactions extract was diluted to 40% with buffer
containing 3 mM ATP, 50 mM K2HPO4, pH 7.0, 2% PEG 8000, 3.5 mM
MgCl2, 1 nM [
32P]UTP-labeled actin, and Prp5 from 2 to 100 nM. Reac-
tion mixtures were incubated at room temperature for 30 min and
extracted as described (25).
Determination of Size—10 ml of 1 mM Prp5 was loaded onto a Super-
ose 12 column equilibrated in 100 mM KCl, 50 mM Tris, pH 7.4, 5%
glycerol, 1 mM DTT, 1 mM EDTA. The void volume was determined by
blue dextran, and standards were run separately to determine a stand-
ard curve for size determination.
ATPase Activity—ATPase activity was determined as follows. RNAs
from 50 to 500 nM were annealed in 60 mM HEPES, pH 7.4, 4% PEG
8000, 2 mM DTT, 100 mMKCl in 10 ml. This solution was heated to 70 °C
for 5 min and snap-cooled on ice. 10 ml of buffer containing 7 mM MgCl2,
500 mM ATP, 1 mCi of [32P]ATP, 0.2 mg/ml bovine serum albumin, 20 nM
Prp5 were added to start the assay. Reactions were incubated at 23 °C,
and 2-ml aliquots were taken every 5 min and spotted on a polyethyl-
eneimine TLC plate. Plates were developed in 0.75 M LiCl, 1 M formic
acid for 2 h, dried, and analyzed by PhosphorImager for the fraction of
ATP hydrolyzed.
Transcription and Purification of RNAs—T7 transcripts of U1, U2,
U2D107, U4, U5, and U6 were made. U1DNC is an internal deletion of
U1 created by a cleavage of the DNA template at the StyI and HindIII
sites of the yeast U1 gene and religation with the four oligonucleotides,
4a 4b, 5a, and 5b. Oligonucleotides 4a and 5a constitute the coding
strand. The sequence of U1DNC is similar to the biologically active U1
constructs prepared by Siliciano et al. (26). Truncations of U2 were
made by cutting the T7U2 plasmid at the BanI and EcoN1 sites. The 39
end of U2, U2 39 end, was created by PCR from nucleotide 126 of
U2D107 (27) to its 39 end. This PCR product, also containing the T7
promoter, was then cloned and transcribed (see Fig. 5). Transcription
reactions typically contained 50 mg of plasmid, 80 mM HEPES, pH 7.4,
12 mM MgCl2, 3 mM NTPs in each, 40 nM DTT, 0.1 units of pyrophos-
phatase, and 1200 units of T7 RNA polymerase/ml. Reactions were
carried out at 37 °C for 4 h. Transcripts were loaded on a 4-mm 6–8%
denaturing polyacrylamide gel (20:1, acrylamide:bisacrylamide). The
transcripts were visualized by UV shadowing, excised, eluted in 500 mM
sodium acetate, pH 5.3, 10 mM EDTA. Eluants were filtered, extracted
with 1:1 phenol/chloroform equilibrated in 0.2 M NaOAc, pH 5.3, ex-
tracted with chloroform, and precipitated twice. Concentrations were
determined by optical density.
Isolation of Polyuridine—Polyuridine obtained from Sigma was dis-
solved to 10 mg/ml in water. Samples were prepared at 0.1 mg/ml in 50
mM Na2CO3:NaHCO3, pH 9.2. The samples were incubated at 90 °C for
10 min. The reaction was stopped by addition of sodium acetate. A small
sample was radiolabeled with [g-32P]ATP and polynucleotide kinase
and then added to the reaction to visualize bands. Samples were loaded
onto a 20% denaturing sequencing gel with several small labeled RNAs
to calibrate the size. Bands were excised as 5–8-, 9–11-, 12–15-, 16–18-,
19–21-, 22–25-, 26–30-, 60–80-, 80–100-, and 100–120-mers. Longer
pieces were similarly isolated by running the samples on an 8% gel.
ATPase activity was assayed as described above except for the following
alterations. 10 nM RNA was assayed in 20 mM sodium phosphate, pH
7.0, 4% PEG 8000, 2.5 mM MgCl2, and 1 mM DTT. ATP concentrations
remained the same.
RNaseH Probing—Extracts were inactivated at 37 °C for 30 min as
described previously. Extracts were diluted in splicing buffer with or
without the presence of 10 nM Prp5. The Sru2 oligonucleotide comple-
mentary to nucleotides 29–43 of U2 RNA was added to 220 nM to start
the reaction. The RnaseH is endogenous to the extract (28). Assays were
incubated at 30 °C for the indicated amount of time. In the same
manner oligonucleotide d1 was added for RNaseH probing of U6 RNA
as described by Fabrizio et al. (29). RNAs were extracted as described
previously, ethanol-precipitated, and electrophoresed on a 4% 20:1 gel
for 3 h at 400 V. The gel was blotted onto a nylon membrane (Gene-
Screen) in 25 mM K2HPO4, pH 6.5, overnight at 25 V. The blot was
cross-linked, washed in water, and pre-hybridized in 1 3 HYB (100 mM
PO4 buffer, pH 7.0, 1 M NaCl), 1% SDS, 100 (mg/ml sonicated salmon
sperm DNA) at 65 °C for 2 h. Random primed probes (Boehringer
Mannheim) were prepared using as template excised fragments of U1,
U2, U4, and U6 DNA purified on glassmilk or GeneClean (BIO-101). A
random primed probe was added to the blot and incubated overnight at
65 °C. The blot was washed once in 1⁄2 3 HYB 1% SDS for 30 min at
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65 °C. The blot was washed two more times in 1⁄2 3 HYB at 65 °C and
autoradiographed.
RESULTS
Purified Prp5 Protein Is a Monomer That Reconstitutes Splic-
ing Activity in Vitro—Previously Dalbadie-McFarland and
Abelson (8) reported the sequence of PRP5 gene clones from
Saccharomyces cerevisiae. Utilizing the cloned gene, we con-
structed vectors for expression of Prp5 in E. coli and yeast. Fig.
1A shows an SDS-PAGE of histidine-tagged Prp5 expressed in
E. coli and purified by chromatography on Ni-NTA, Sepharose
S, and Mono Q as described under “Materials and Methods.”
Expression levels for Prp5 protein were consistently low under
a variety of growth conditions. However, we were able to purify
significant quantities of the protein using affinity tagged con-
structs (Fig. 1). Immunoblot analysis of Prp5 produced in E.
coli using anti-Prp5 sera revealed multiple sized polypeptides
and very little full-length protein (data not shown). Analysis of
the nucleotide sequence of PRP5 indicated that several sites
within the gene could be prokaryotic translation start sites.
Probably the Prp5 fragments represent initiation at internal
sites because when Prp5, N-terminally tagged with the flag
peptide, was expressed only full-length protein was detected by
the anti-flag antibody.
Prp5 protein was overexpressed in 10 liters of LB broth. Cells
were lysed by sonication; the nucleic acids precipitated by
polyethyleneimine, and the debris removed with a high speed
spin. The extract was passed over a Ni-NTA column in pH 7.0
phosphate buffer. Attempts to purify protein at a higher pH or
with Tris buffer resulted in very low recovery. The histidine tag
may have been only partially accessible to the affinity ligand.
The pI of Prp5 is approximately neutral, and this was exploited
by successive chromatographic separations on Sepharose S at
pH 6.5 and Mono Q at 8.0. Analyses of the pooled fractions from
the different column separations by SDS-PAGE are shown in
Fig. 1A. The purified protein was stored at 270 °C. Storage at
220% in 50% glycerol as well as freezing and thawing of the
protein resulted in partial loss of activity.
Purified Prp5 was assayed for the ability to reconstitute the
splicing activity of heat-inactivated yeast extracts from the
prp5-1 mutant strain. As seen in Fig. 1B, the splicing activity
on the prp5-1 extract was evident but poor before heat treat-
ment. Incubation at 37 °C abolished all activity. Addition of
increasing concentrations of purified Prp5 to the heat-treated
extract resulted in increasing levels of splicing activity. Recom-
binant Prp5 can reconstitute splicing activity at concentrations
as low as 2 nM, but splicing activity is enhanced at higher
concentrations (Fig. 1B). Purified Prp5 also reconstituted splic-
ing activity of heat-treated extracts from the prp5-3 mutant
strain (data not shown). Purified His-tagged Prp5 expressed in
yeast was equally as active as the E. coli expressed protein
(data not shown). Taken together, these results indicate that
purified Prp5 contains all of the activities required to comple-
ment extracts in which the protein has been inactivated.
The native molecular weight of Prp5 was determined by size
exclusion chromatography. A Superose 4B column was cali-
brated, and Prp5 was loaded in 100 mM NaCl to determine its
multimeric state. Although Prp5 had some tendencies to ag-
gregate during the purification procedure, size exclusion chro-
matography detected a protein of about 100 kDa, the approxi-
mate size of Prp5. Although more experiments would have to be
done to determine whether or not Prp5 functions as a dimer as
do many DNA helicases (30, 31), in the absence of substrate it
is primarily a monomer.
Prp5 Is an RNA-dependent ATPase—Most members of the
DEAD family of proteins are RNA-dependent ATPases. On its
own, purified Prp5 showed virtually no ATPase activity. How-
ever, in the presence of RNA homopolymers, significant levels
of ATPase activity were seen with the purified protein. Analy-
sis of several different nucleic acid homopolymers indicated
that poly(rU) and poly(rI) were best able to stimulate activity.
In general the activity of poly(rI) is greater than or equal to
poly(rU) . poly(rA) . poly(rC) (Fig. 2). This activity is relative
since the average size of the homopolymers was not controlled.
Deoxyribonucleic acids were not active (data not shown). Ac-
FIG. 1. A, SDS-PAGE of protein fractions from Prp5 purification. From left to right: molecular weight markers, U, 10 mg of uninduced cell
extract; I, 10 mg of induced cell extract; Ni, 5 mg of Ni-NTA elution; Q, 2.5 mg of Mono Q elution; S, 2.5 mg of Mono S elution. Protein was visualized
by silver staining. B, reconstitution of pre-mRNA splicing activity with recombinant Prp5. Reconstitution was performed with the indicated
concentration of Prp5 in prp5-1 extract preheated to 37 °C for 30 min. C denotes prp5-1 extract without heat or added protein. Splicing activity
was assayed using the actin pre-mRNA substrate.
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tivity stimulated by poly(U,G) was found to be similar to
poly(U). Using size-fractionated rU homopolymers, we investi-
gated the size dependence of the RNA stimulatory activity.
Polyuridine was partially base-hydrolyzed, and polymers of
defined lengths were isolated. At saturating levels of RNA,
Prp5 had virtually no ATPase activity until the polymer length
was approximately 25–30 nt, and maximum activity was ob-
served at about 100 nt (see Fig. 3). Longer polymer mixtures
(;800 nt average length) did not stimulate the ATPase activity
to a greater extent than the 100-nt polymer (data not shown).
Apparently the optimum binding site is about 100 nt in length.
The Prp5 ATPase Activity Is Stimulated Specifically by U2
RNA—We tested the ability of the five spliceosomal snRNAs to
stimulate ATPase activity. The sizes of these snRNAs are ex-
tremely variable; therefore, to facilitate our analysis we uti-
lized truncated versions of the U1 and U2 snRNAs, U1DNC and
U2D107, respectively, to make RNAs of similar lengths. The
U1DNC clone is similar in size to mammalian U1 and to a
similar deletion studied by Siliciano et al. (26) and found to be
active in vivo. U2D107 is a truncation of the yeast U2 RNA
which is also active in vivo (27). Of the five snRNAs tested,
U2D107 exhibited the highest ATPase stimulatory activity
(Fig. 4A). The U5 snRNA showed a level of stimulation similar
to the 100-nt poly(rU) fragment. A comparison of the RNAs
tested and their apparent Km and kcat values are tabulated in
Table I. As seen in Fig. 4 and in Table I, U2 is about 2.5 times
better in overall specificity as compared with the next best
substrate, U5. When Km and kcat values were calculated, it was
found that U5 bound slightly tighter, but had a 4-fold lower
kcat. Similarly poly(U100) has a similar Km but has a 4-fold
lower Vmax. The activities of the other snRNAs were too low to
determine with any reliability.
Although U1DNC-stimulated ATPase activity above back-
ground, ATPase activity did not increase linearly with sub-
strate (Fig. 4, A and B). It is possible that this RNA is saturat-
ing at low concentration but has very little activity. However,
in competition experiments (not shown) U1DNC RNA was not
an effective competitor of U2 RNA in the RNA-dependent
ATPase reaction. The experiments shown in Fig. 4 and Table I
were repeated a number of times, and although the absolute
value for Km/kcat varied as much as 2-fold from experiment to
experiment the ranking of RNAs in activity remained the same.
U2 RNA always was most effective in stimulating the ATPase
activity.
To identify specific regions of the U2 snRNA responsible for
stimulation of Prp5 ATPase activity, we assayed several U2
deletions for activity. Two 39 deletions and one 59 deletion were
prepared as described under “Materials and Methods.” A dia-
gram of these RNAs as well as the full-length U2 snRNA
(U2FL) are shown in Fig. 5. ATPase assays with Prp5 and the
various U2 RNAs were performed, and the kinetic parameters
Km and kcat were determined if possible for each RNA (Table
II). Both U2D107 and U2FL had similar Km values; the full-
length having a 2–3-fold larger kcat than U2D107 and almost
FIG. 3. ATPase activity of recombinant Prp5 using various
length uridine polymers. ATPase was assayed as described under
“Materials and Methods” using 20 nM Prp5 and 10 mM RNA polymers.
u, rate (mol ATP/minliter 31026.
FIG. 2. ATPase activity of recombinant Prp5 using various
homopolymers. 0.2 mg of various homopolymers was added to a 20-ml
reaction with 100 nM Prp5 and [g-32P]ATP. TLC was performed as
stated under “Materials and Methods.” Substrates used from left to
right: a, poly(rU); b, poly(rC); c, poly(rA); d, poly(rUG); e, poly(rI); f, no
RNA.
FIG. 4. ATPase activity of recombinant Prp5 using various
snRNAs and a homopolymer. A, TLC of reaction mixtures containing
various concentrations of RNA after 30 min incubation. B, rate of
hydrolysis versus [RNA]. Note that hydrolysis of U1DNC is above back-
ground but does not increase with increasing concentrations of RNA. M,
mol/min pU (26–30); L, mol/min U1DNC; E, mol/min U2D107; ,
mol/min U5.
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7-fold greater specificity than the next best substrate, U5. With
the U2Ban deletion, the kcat lowered at least 10-fold, and no
activity was seen with U2EcoN1. These values agree with the
activity of these U2 variants in the reconstitution assay (28).
Full-length U2 is best able to reconstitute activity but U2D107
can also reconstitute activity to at least 50% of wild type.
U2Ban has both a low reconstitution activity and a low ATPase
stimulatory activity. EcoN1 and the 39 end fragment were
inactive in both assays. Thus a good correlation can be made
between splicing activity and ATPase activity, but we were
unable to delineate a specific region of U2 that interacts with
Prp5 to activate the ATPase.
A number of different substrates were constructed to test for
helicase activity including the pGEM/pSP runoff transcript and
the U4/U6 RNA used by Claude et al. (16), the rGC transcript
used by Rozen et al. (14) on eIF-4A, and substrates represent-
ing the branch point and hairpin/pseudoknot regions (A A9, B9
B, and C C9 of U2) proposed by Ares and Igel (35). No helicase
activity was seen in any of these assays under a variety of
conditions (data not shown).
ATP-dependent Changes in the U2 snRNP Structure Are
Mediated by Prp5—Further evidence that Prp5 interacts with
U2 snRNA was obtained from an RNaseH structure probing
experiment. Previously McPheeters and Abelson (28, 29) used
an oligonucleotide complementary to the branch point interac-
tion site in U2 to target the RNaseH-dependent destruction of
U2 RNA for complementation experiments. This reaction was
discovered to be partially ATP-dependent (28, 29). To address
the mechanism of ATP-stimulated cleavage, we tested whether
degradation of the U2 RNA mediated by the branch point oligo
was also Prp5-dependent. We performed RNaseH cleavage re-
actions in the prp5-1 mutant extract and monitored the cleav-
age of the U2 snRNA. Fig. 6 shows a time course of degradation
in the heat-treated prp5-1 extract. RNaseH activity in the
absence of Prp5 protein is slow, with significant amounts of
full-length U2 remaining after 20 min. When Prp5 protein was
added, cleavage of U2 was significantly faster, with little or no
full-length U2 remaining after 10 min of degradation.
There is always some background or ATP-independent deg-
radation of U2 RNA. We believe that this is due to alternate
and perhaps less active or incomplete forms of the U2 snRNP in
extracts. Extracts that splice poorly contain more of this form of
the snRNP than do more active extracts.
To verify that the Prp5 effect was specific to U2, we assayed
the ATP-dependent oligonucleotide-directed degradation of U6
RNA in the presence and absence of Prp5. (Fig. 7). In prp5
extracts d1-directed degradation is ATP-dependent, but the
addition of Prp5 had no effect (29).
DISCUSSION
In this paper, we describe the initial experiments in a pro-
gram to explore the role of the spliceosomal ATPase, Prp5 in
the process of spliceosome assembly. We have adapted the
enzyme for purification by adding 10 histidine residues to the N
terminus allowing for a powerful metallo-affinity step in the
purification. Overall the purification is simple, rapid, and re-
producible, and the protein retains activity during storage at
220 °C. The N-terminal histidines did not affect the activity of
the protein in an in vitro complementation assay. The histidine
tagged Prp5, whether purified from yeast or E. coli, is fully able
to restore activity to a prp5-1 heat-inactivated extract.
Purified Prp5 behaves as a monomer as judged by its mobil-
ity in size exclusion chromatography. Many DNA helicases act
as dimers although they too can be monomers in the absence of
substrate (30, 31). More experiments are necessary to deter-
FIG. 5. List of the various U2 variants used for the ATPase
assay. The length and the proposed secondary structures are listed.
The numbering given after the schematic of the RNA is the numbering
system for the full-length U2. In U2D107 and U2 39 end, the 39 end
contains an 892-base pair deletion which is religated with a 10-base
pair linker as described (27).
TABLE I
Prp5 substrates
RNA Length Km Vmax kcat/Km
nt nM mmol ATP/min
liter
U2D107 283 438 2.56 5.8
U1DNC 223 NAa NA ,0.43
U5 267 267 0.60 2.25
U4 161 NA NA ,0.43
U6 113 NA NA ,0.43
pU (25–30) 25–30 NA NA ,0.43
pU (80–100) 80–100 644 0.73 1.14
a NA, activity too low to be determined.
TABLE II
U2 RNA variants
RNA Length Km Vmax kcat/Km
nt nM mmol ATP/min
liter
U2D107 283 438 2.56 5.8
U2FL 1177 574 8.69 15
U2Ban 125 184 0.08 0.43
U2EcoN1 78 NAa NA ,0.43
U23end 159 NA NA ,0.43
a NA, activity too low to be determined.
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mine whether Prp5 acts as a multimer.
Some of the DEAD box family members can act as RNA
helicases, that is they possess the ability to separate the
strands of double strand RNA (13–17). It is this activity that
naturally attracts attention to this group of proteins in the
context of RNA splicing. During spliceosome assembly, a num-
ber of changes take place in the interactions between snRNAs
and the pre-mRNA substrate and between snRNAs. For exam-
ple, U4 and U6 RNA enter the spliceosome as a complex joined
together by 21 base pairs, but at a later step in the assembly
process, this helical interaction is displaced, U4 leaves the
spliceosome and U6 enters into a new set of interactions with
the substrate, with U2 RNA, and with itself (3). This is a
reaction which is probably catalyzed, and since ATP hydrolysis
is required for this step, one imagines that it could be catalyzed
by a member of this family, although as yet none has unam-
biguously been assigned. Consequently we have tested the
ability of Prp5 to act as a helicase using a variety of substrates
that have been previously described. No helicase activity was
seen. As outlined in the introduction, there is strong evidence
that implicates Prp5 in the formation of the pre-spliceosome.
There are as yet no known RNA transformations at this stage
of spliceosome assembly. Possible rearrangements include a
destabilization in the base pairing interaction of U1 RNA with
the 59 splice site or some change in the conformation of U2 RNA
which allows it to form a base pairing interaction with the
branch point sequence near the 39 splice site of the intron. More
information will be necessary to allow us to design an assay for
the relevant RNA transformation catalyzed by Prp5.
Like Prp5, most of the proteins in this class that have been
tested do not exhibit RNA helicase activity. Possibly they
too have specific substrates that have not yet been identified.
However, most members of the family are RNA-dependent
ATPases, and this is true of Prp5 as well. In the absence of
RNA, Prp5 exhibits no ATPase activity over background. How-
ever in the presence of a number of different RNAs there is a
low but clearly detectable level of ATPase. Among the ho-
mopolymeric substrates we tested, poly(U) and poly(I) are the
most effective stimulant of the ATPase activity. We tested a
size fractionated set of poly(U) oligomers, and the optimum size
was about 100 nucleotides. This might indicate a rather large
binding site in the enzyme, or it could be that for optimum
ATPase activity more than one enzyme molecule must interact
with the substrate.
We tested all of the yeast spliceosomal snRNAs for activity in
stimulating the Prp5 ATPase activity. Of those tested only U5
RNA and U2 RNA showed activity, with U2 RNA being most
effective. Specificity is 7-fold greater for the full-length U2 than
U5 RNA but only 2.5-fold greater for U2D107. Although the
degree of specificity that is seen here is modest, this was an
encouraging result since much previous work had indicated an
interaction between Prp5 and U2 RNA. We constructed a num-
ber of deletions of U2 RNA and tested them for activity in this
assay. This approach could have identified a sub-domain of U2
RNA responsible for the stimulatory activity. No such domain
was identified. The most active RNA is the full-length 1175-nt
U2 RNA. We observed a correlation between the activity of
variants of U2 RNA in a reconstitution assay and the ability of
that species to stimulate Prp5 ATPase activity (28). This might
be expected if only a particular conformation of U2 is active in
both assays, and this conformation cannot be achieved in single
domains.
The Prp5 specificity for U2 RNA does not appear to be due to
RNA length. Referring to Table I, U2D107 has more than a
10-fold higher kcat/Km than U1DNC which is about the same
size (283 versus 223 nts) and U4 RNA which is more than half
the size (283 versus 161 nts). For U5 RNA (283 versus 267 nts)
the difference is over 2-fold. Furthermore, the ATPase activity
stimulated by poly(U) RNA is not increased by increasing the
average size of the RNA from 100 to ;800 nts (data not shown).
Although full-length U2 RNA is about 3-fold more active than
D107, deletion variants about half the length of U2D107 (cf.
U2Ban and U2EcoN1, Table II) show no detectable activity
despite the fact that they are larger than the optimum poly(U)
substrate. These results taken together with the observation
that the activity of U2 RNA in stimulating Prp5 ATPase activ-
ity is highly dependent on the salt and buffer conditions in the
reaction suggest that the specificity, although modest, is due to
Prp5 recognition of some feature of U2 secondary or tertiary
structure, perhaps a state that is not fully occupied under the
conditions of the in vitro assay but is more represented in the
population of full-length U2 RNA molecules.
It is encouraging that some RNA specificity can be seen in
the Prp5 RNA-dependent assay since this had not yet been
observed for any spliceosomal ATPase. However, the degree of
FIG. 6. Time course of RNaseH digestion of the endogenous U2
snRNA using the oligonucleotide Sru2 (28), in the presence and
absence of recombinant Prp5 in a heat-inactivated 5-1 extract.
4% PAGE gels were blotted and probed for U2 and U1 snRNAs. DU2
denotes the degraded form of U2 after RNase digestion which is known
to be the 39 end of U2 up to the Sm binding site. U1 is probed as a
control.
FIG. 7. RNaseH digestion of the endogenous U6 snRNA using
the oligonucleotide d1, in the presence and absence of recom-
binant Prp5 and ATP (29). 7% PAGE gels were blotted and probed for
U4 and U6 snRNAs. The degraded U6 cannot be visualized, but U4 was
probed as a control.
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specificity, at best 10-fold over poly(U), is very modest when
compared with the specificity of the E. coli DEAD box protein
DbpA (32). DbpA is an RNA-dependent ATPase that is abso-
lutely dependent on 23 S rRNA. Furthermore, all of the activity
can be traced to a 93-nucleotide segment of the RNA in domain
V near the 530 loop. Clearly this subdomain can fold into an
optimum substrate for DbpA in the absence of the complete
RNA or any accessory protein. It is ironic, however, that the
biological function of DbpA is unknown and its substrate beau-
tifully accessible, while the biological function of Prp5 is well
understood and its substrate comparatively obscure.
Earlier, we had developed a U2 RNA complementation sys-
tem in which the endogenous U2 RNA in the extract is de-
stroyed by incubation of the extract with a deoxyoligonucle-
otide complementary to the branch point interaction region in
U2 RNA (28). In this assay, U2 RNA is cleaved by endogenous
RNaseH, and the deoxyoligonucleotide is destroyed in time by
endogenous DNases. Activity is restored by addition of syn-
thetic U2 RNA. In developing this assay David McPheeters
noted that the RNaseH destruction of U2 is partially dependent
on added ATP. In this paper we demonstrate that this effect is
mediated by Prp5. No ATP effect on RNaseH cleavage of U2
RNA is seen in a heat-inactivated prp5-1 extract, but the effect
can be restored by addition of purified Prp5 and ATP. In the
accompanying paper (33) we demonstrate that the same effect
extends to the U2cs mutants, G53A and C62U (34), and also to
prp9, prp11, and prp21 extracts. Although this is not a quan-
titative assay, we believe that it is a biologically relevant one
because all of the factors seem to interact with prp5-1 geneti-
cally (21, 23, 24); the U2cs mutants in stem II, prp9, prp11, and
prp21 also affect this assay. Addition of purified
Prp9zPrp11zPrp21 to the Prp5 U2 RNA-dependent ATPase as-
say had very little effect on ATP hydrolysis levels (data not
shown). Contaminating ATPase activity of the complex, how-
ever, made interpretation difficult. In light of the results in the
accompanying paper (33), this is a promising avenue to explore
under more defined reaction conditions. The RNaseH potenti-
ation effect suggests that Prp5, in conjunction with Prp9,
Prp11, and Prp21, acts on the U2 snRNP, most likely through
the stem II structure (35), and induces a conformational change
that exposes the branch point pairing sequence. This is indeed
a reaction that would be relevant to the formation of the pre-
spliceosome. What remains to be discovered is precisely what
Prp5 does to U2 RNA in that reaction. It is possible that the
transformation in U2 RNA structure only takes place in the
context of the U2 snRNP.
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